Skip to content
FrontierPicks

Watchlist

NSP · Insperity, Inc

Conviction · LOW Special situation Catalyst · Prediction markets & betting

Last analysed ·

Against its published line

Nothing is through its line on this close.

How to read this

The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 18 September 2026; a dot LEFT of the mark has closed through its line.

Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.

How a pick resolves

NSPInsperity, Inc
$48.00
$50.31
+4.8%

Current thesis

Insperity's margin-repair re-rating requires a weekly close above $53.40 before a weekly close below $48. Third-quarter employee volumes must meet the 305,500 guidance floor and the full-year adjusted EBITDA floor must remain at least $185 million to confirm the operating case.

Kill line

A weekly close below $48 ends the recovery-price thesis; Q3 average paid worksite employees below 305,500 or a full-year adjusted EBITDA guidance floor below $185 million would separately invalidate the operating case.

Pick status

Open commitment catalyst in 10dscored if the kill line above fires How this is scored →

Latest analysis and events for NSP —

As of 20 September 2026, the latest FrontierPicks analysis for Insperity, Inc (NSP): Insperity's margin-repair re-rating requires a weekly close above $53.40 before a weekly close below $48. Third-quarter employee volumes must meet the 305,500 guidance floor and the full-year adjusted EBITDA floor must remain at least $185 million to confirm the operating case.

Kill line: A weekly close below $48 ends the recovery-price thesis; Q3 average paid worksite employees below 305,500 or a full-year adjusted EBITDA guidance floor below $185 million would separately invalidate the operating case.

Next dated event on file: — catalyst in 10d.

Current Thesis

Insperity's margin-repair re-rating requires a weekly close above its $53.40 adjusted high before a weekly close below $48, with third-quarter employee volumes testing whether the operating recovery holds. The 2026-09-18 adjusted close was $50.31, 5.8% below that high, despite a three-month price gain of 49.2%. The fundamental anchor remains the company's 2026-07-29 guidance: full-year adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $185–225 million.

The narrative is maturing — the July earnings guidance remains the operating anchor, while the 2026-09-18 14-day relative strength index (RSI) of 38.3 indicates weak recent price momentum. This is an inference from the supplied price measures, not a measurement of investor flows. Argus raised its published target to $54 on 2026-09-16, adding a dated valuation opinion without establishing a change in company earnings. Argus quantitative report

Bullish and bearish views on Insperity, Inc

The model's bull view on Insperity, Inc (NSP), in brief: Profit recovery has reported support. Insperity's 2026-07-29 release reported second-quarter adjusted EBITDA of $36 million, up 13% year over year. That supports the margin-repair interpretation; a full-year guidance floor below $185 million would break its fundamental anchor.… The bear view: Gross profit still contracted. The 2026-07-29 second-quarter release reported revenue of $1.686 billion, up 2% year over year, alongside gross profit of $217 million, down 3%. Revenue growth therefore had not produced gross-profit growth in that quarter. The next quarter permits… Both cases follow in full.

Bull Case

  • Profit recovery has reported support. Insperity's 2026-07-29 release reported second-quarter adjusted EBITDA of $36 million, up 13% year over year. That supports the margin-repair interpretation; a full-year guidance floor below $185 million would break its fundamental anchor.
  • Employee guidance became less negative. On 2026-07-29, Insperity raised its full-year average paid worksite employees (WSEEs) guidance to 305,000–307,000 from 303,000–307,000. Second-quarter average paid WSEEs were 305,764; a third-quarter result below the guided 305,500 floor would contradict the stabilization case.
  • A fresh valuation revision appeared. Argus's 2026-09-16 quantitative report raised its target to $54. This establishes a new third-party revision, but does not establish broader analyst participation or a revenue upgrade. Argus report

Bear Case

  • Gross profit still contracted. The 2026-07-29 second-quarter release reported revenue of $1.686 billion, up 2% year over year, alongside gross profit of $217 million, down 3%. Revenue growth therefore had not produced gross-profit growth in that quarter.
  • The next quarter permits weakness. Insperity's 2026-07-29 third-quarter guidance allowed adjusted earnings per share between a $0.09 loss and a $0.41 profit, with adjusted EBITDA of $14–41 million. The guidance itself leaves substantial uncertainty around the next earnings outcome.
  • The partnership lacks disclosed output. The 2026-07-29 disclosures identified Workday HRScale partnership costs of $8 million in the second quarter and $16 million year to date, without a client count or partnership revenue in the supplied earnings record. Those costs alone do not establish commercial traction.

Setup & Price Structure

The 2026-09-18 adjusted close of $50.31 sits below the market's $53.40 adjusted 52-week high. The supplied three-month gain of 49.2% and RSI of 38.3 describe a strong preceding advance with weaker recent momentum. The research case reaches its price objective on a weekly close above $53.40 before the $48 weekly-close invalidation fires; neither the gain nor the RSI establishes that this sequence will occur.

The $48 threshold remains a fixed research condition. A current moving-average value is unavailable, so that threshold is not presented as today's moving average. The low-conviction forecast reflects the weak 2026-09-18 momentum reading and the unresolved third-quarter operating range published on 2026-07-29.

The observable attention evidence is limited. Insperity's newsroom lists HRScale coverage dated 2026-09-03 and HRCore coverage dated 2026-09-16; Argus published its target revision on 2026-09-16. This sample is too small to support a crowding claim. Current short interest, fund flows and retail participation measures are missing. Insperity newsroom Argus report

Catalyst Calendar (next 30 days)

  • 2026-09-30 — ADP employment report. ADP's published calendar confirms this release date. Establishment-size employment data provide an external comparison for small-business hiring; they do not directly measure Insperity's WSEEs. ADP release calendar
  • 2026-10-02 — September employment report. The Bureau of Labor Statistics confirms this date. Professional and business services employment provides a sector comparison for the employee-volume thesis, whose direct test remains Insperity's third-quarter WSEE result. BLS release schedule
  • ~2026-11-02, estimated — Third-quarter results. This later event is the operating test: average paid WSEEs against the 305,500–307,500 range and adjusted EBITDA against $14–41 million, both issued on 2026-07-29. The date remains a historical-calendar estimate; Insperity's investor-relations page checked on 2026-09-20 did not identify the next call date. Insperity investor relations

What Would Change Our Mind

Loss of the retained recovery threshold would end the price thesis: a weekly close below $48 is the observable invalidation. A third-quarter average paid WSEE result below 305,500, or a reduction of the full-year adjusted EBITDA guidance floor below $185 million, would separately break the operating assumptions established on 2026-07-29.

A weekly close above the $53.40 adjusted high reported as of 2026-09-18 would complete the defined price case if it occurred before invalidation. Third-quarter WSEEs within or above the published range, together with retention of the full-year earnings floor, would provide company-level confirmation of the margin-repair interpretation.

Correlation Notes

This is a single-company margin-repair setup; no measured peer or index correlation is available as of 2026-09-20. The 2026-09-30 ADP release and 2026-10-02 BLS release are hiring comparisons, not evidence that Insperity tracks either series. Insperity's own 2026-07-29 employee-volume and profitability guidance supplies the gradeable operating tests, so a broad labor-market improvement alone cannot establish that the thesis has played out.

Notes

  • Core volume metric is average paid worksite employees (WSEEs): 305,764 in Q2 2026; the FY guide of 305,000-307,000 still implies a 1.0-1.6% full-year decline.
  • The PEO model carries client health-benefit costs, so medical-cost inflation hits gross profit directly; that pass-through, not demand, drove the 2025 drawdown to $18.57.
  • Earnings seasonality is severe: FY26 adjusted EBITDA guided $185-225M against a Q3 range of $14-41M, so quarter-to-quarter comparisons are not linear.
  • Sell-side coverage is thin (roughly three to five firms) and published targets after the Q2 print ranged from JPMorgan's $33 to Roth Capital's $59; one revision moves the aggregate.
  • Quarterly dividend is $0.60 ($2.40 annualized); it went ex on 2026-09-02, so the adjusted price series reads below unadjusted quotes from before that date.

Related · shared themes